Your browser doesn't support javascript.
loading
Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the EMPEROR-Reduced Trial.
Khan, Muhammad Shahzeb; Anker, Stefan D; Filippatos, Gerasimos; Ferreira, João Pedro; Pocock, Stuart J; Januzzi, James L; Chopra, Vijay K; Piña, Ileana L; Böhm, Michael; Ponikowski, Piotr; Verma, Subodh; Brueckmann, Martina; Vedin, Ola; Peil, Barbara; Zannad, Faiez; Packer, Milton; Butler, Javed.
Afiliación
  • Khan MS; Division of Cardiology, Duke University School of Medicine, Durham, NC, USA.
  • Anker SD; Department of Cardiology and Berlin Institute of Health Center for Regenerative Therapies; German Centre for Cardiovascular Research Berlin, Germany; Charité Universitätsmedizin Berlin, Berlin, Germany; Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.
  • Filippatos G; National and Kapodistrian University of Athens School of Medicine, Athens University Hospital Attikon, Athens, Greece.
  • Ferreira JP; Université de Lorraine, INSERM, Centre d'Investigations Cliniques Plurithématique 1433, Inserm U1116, CHRU de Nancy and F-CRIN INI-CRCT, Nancy, France; Cardiovascular Research and Development Center, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto, Portuga
  • Pocock SJ; Department of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK.
  • Januzzi JL; Harvard Medical School, Massachusetts General Hospital, Baim Institute for Clinical Research, Boston, MA, USA.
  • Chopra VK; Department of Cardiology, Medanta, Gurgaon, Haryana, India.
  • Piña IL; Department of Medicine, Thomas Jefferson University, Philadelphia, PA.
  • Böhm M; Department of Internal Medicine III, University Hospital Saarland, Saarland University, Homburg, Saar, Germany.
  • Ponikowski P; Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.
  • Verma S; Division of Cardiac Surgery, St Michael's Hospital, University of Toronto, Toronto, Canada.
  • Brueckmann M; Boehringer Ingelheim International GmbH, Ingelheim, Germany; First Department of Medicine, Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany.
  • Vedin O; Boehringer Ingelheim AB, Stockholm, Sweden.
  • Peil B; Boehringer Ingelheim Pharma, Ingelheim, Germany.
  • Zannad F; Université de Lorraine, INSERM, Centre d'Investigations Cliniques Plurithématique 1433, Inserm U1116, CHRU de Nancy and F-CRIN INI-CRCT, Nancy, France.
  • Packer M; Baylor University Medical Center, Dallas, TX, USA; Imperial College, London, UK.
  • Butler J; Baylor Scott and White Research Institute, Dallas, TX, USA; Department of Medicine, University of Mississippi School of Medicine, Jackson, MS, USA. Electronic address: Javed.Butler@bswhealth.org.
J Card Fail ; 29(10): 1345-1354, 2023 Oct.
Article en En | MEDLINE | ID: mdl-37558088

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: J Card Fail Asunto de la revista: CARDIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: J Card Fail Asunto de la revista: CARDIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos